Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v2.3.0.15
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands
 6 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities:    
Net income $ 24,629 $ 9,365
Reconciliation of net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,191 1,427
Exchange rate (gain) loss (2) (8)
Deferred taxes 12,034  
Restructuring 277  
Gain on sale of CNS assets (31,654)  
Gain on sale of non-operating assets (325)  
Stock-based compensation 667 580
Changes in operating assets and liabilities:    
Accounts receivable 6,226 (7,100)
Inventory 13 3,551
Prepaid expenses and other current assets 827 376
Other assets 42 48
Deferred revenue 229 263
Accounts payable and accrued expenses (16,241) 1,946
Accrued compensation (2,551) (1,098)
Net cash provided by (used in) operating activities (4,638) 9,350
Cash flows from investing activities:    
Maturities of held-to-maturity debt securities 503  
Maturities of other investments 490  
Purchases of held-to-maturity debt securities (13,868)  
Purchases of other investments (5,481)  
Purchases of property and equipment (697) (359)
Proceeds from sale of non-operating assets 325  
Restricted cash (3,350)  
Proceeds from sale of CNS assets 36,683  
Net cash provided by (used in) investing activities 14,605 (359)
Cash flows from financing activities:    
Proceeds from stock options exercised 1,578 314
Purchases of treasury stock (8,825) (555)
Net cash provided by (used in) financing activities (7,247) (241)
Effect of exchange rate changes on cash (102) 10
Net increase in cash and cash equivalents 2,618 8,760
Cash and cash equivalents, beginning of period 86,408 61,315
Cash and cash equivalents, end of period $ 89,026 $ 70,075